News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,438 Results
Type
Article (39424)
Company Profile (249)
Press Release (653765)
Section
Business (204045)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80963)
Employer Resources (169)
FDA (16138)
Job Trends (14831)
News (344919)
Policy (32479)
Tag
Academia (2537)
Alliances (49330)
Alzheimer's disease (1317)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (230)
Cancer (1770)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (128)
Cell therapy (368)
Clinical research (65353)
Collaboration (688)
Compensation (379)
COVID-19 (2568)
C-suite (171)
Data (1686)
Diabetes (221)
Diagnostics (6298)
Earnings (85648)
Employer resources (145)
Events (111100)
Executive appointments (583)
FDA (17078)
Funding (619)
Gene therapy (252)
GLP-1 (657)
Government (4362)
Healthcare (18783)
Infectious disease (2685)
Interviews (311)
IPO (16467)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (259)
Manufacturing (241)
Medical device (13275)
Medtech (13280)
Mergers & acquisitions (19333)
Metabolic disorders (572)
Neuroscience (1734)
NextGen: Class of 2025 (6509)
Non-profit (4476)
Northern California (2177)
Obesity (314)
Opinion (196)
Patents (174)
People (56891)
Phase I (20349)
Phase II (28787)
Phase III (21436)
Pipeline (780)
Postmarket research (2563)
Preclinical (8587)
Radiopharmaceuticals (242)
Rare diseases (331)
Real estate (5897)
Regulatory (21972)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1867)
Startups (3569)
United States (19133)
Vaccines (620)
Weight loss (214)
Date
Today (111)
Last 7 days (777)
Last 30 days (2687)
Last 365 days (34338)
2025 (5335)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Arizona (211)
Asia (37548)
Australia (6138)
California (4962)
Canada (1748)
China (410)
Colorado (226)
Connecticut (234)
Europe (80489)
Florida (730)
Georgia (171)
Illinois (463)
Indiana (271)
Japan (126)
Maryland (757)
Massachusetts (3768)
Michigan (200)
Minnesota (344)
New Jersey (1404)
New York (1420)
North Carolina (855)
Northern California (2177)
Ohio (174)
Pennsylvania (1128)
South America (1093)
Southern California (1867)
Texas (725)
Utah (153)
Washington State (475)
693,438 Results for "azitra inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
Azitra, Inc. today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.
May 31, 2024
·
4 min read
Pharm Country
Azitra, Inc. Announces Reverse Stock Split - June 27, 2024
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 30 pre-split shares.
June 27, 2024
·
4 min read
Drug Development
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
Azitra, Inc. today announced preclinical data from the Company’s platform and pipeline.
May 17, 2024
·
5 min read
Pharm Country
Azitra, Inc. Announces Q1 2024 Financial Results and Provides Business Updates
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, reported financial results for the three months ended March 31, 2024, and provided a business update.
May 9, 2024
·
10 min read
Drug Development
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced preclinical data from the Company’s platform and pipeline.
April 22, 2024
·
4 min read
Drug Development
Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced preclinical data from the Company’s platform and pipeline.
May 10, 2024
·
7 min read
Business
Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
Azitra, Inc. today reported financial results for the full year ended December 31, 2023, and provided a business update.
March 15, 2024
·
9 min read
Pharm Country
Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced it will be presenting promising new preclinical data from its platform built to discover treatments for serious skin diseases at three upcoming scientific and medical conferences.
April 18, 2024
·
5 min read
Press Releases
Azitra to Present at BIO-Europe 2024
October 29, 2024
·
2 min read
Pharm Country
Azitra, Inc. Announces Pricing of Public Offering - February 14, 2024
Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, announced the pricing of an underwritten public offering of 16,667,000 shares of common stock.
February 13, 2024
·
3 min read
1 of 69,344
Next
